The chromatin regulator HELLS mediates SSB repair and responses to DNA alkylation damage
Nucleic Acids Research · 26.11.2025 · 53 (22)
DOI: 10.1093/nar/gkaf1201 ↗Kurz gefasst
Fachartikel in der Zeitschrift Nucleic Acids Research, online erschienen am 26.11.2025. Verfasst von Joyous T Joseph und 20 weiteren Autor:innen. Beteiligte Einrichtung: Department of Genetics, University of Alabama, Birmingham, AL 35233, United States. Hauptthemen laut MEDLINE: DNA Helicases, Chromatin, Chromatin Assembly and Disassembly, Neoplasms. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 91 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS, NIDDK NIH HHS, NIGMS NIH HHS.
Abstract (Originalsprache)
The SNF2 family chromatin remodeler HELLS has emerged as an important regulator of cell proliferation, genome stability, and several cancer pathways. Significant upregulation of HELLS has been reported in 33 human cancer types. While HELLS has been implicated in DNA damage response, its function in DNA repair is poorly understood. Here, we report a new regulatory link between HELLS and single-strand break (SSB) repair in cellular responses to DNA alkylation damage. We found that loss of HELLS impairs SSB repair and selectively sensitizes cells to DNA alkylating agents and PARP inhibitors (PARPi). Our data reveal non-epistatic interactions between HELLS and PARP1 and suggest that HELLS functionally compensates for PARP1 deficiency in promoting cell survival in response to DNA alkylation damage. Furthermore, we found that HELLS is co-expressed with PARP1 in cancer cells, and its loss is synthetic lethal with homologous recombination deficiency (HRD). This work unveils new functions of HELLS in modulating SSB repair and responses to clinically relevant DNA alkylation damage, thus offering new insights into the potential therapeutic value of targeting HELLS in cancer.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Genetics, University of Alabama, Birmingham, AL 35233, United States.
- The Hormel Institute, University of Minnesota, Austin, MN 55912, United States.
- Department of Pediatrics, University of Florida, Gainesville, FL 32608, United States.
- Department of Physiology and Biomedical Engineering, Mayo Clinic, Rochester, MN 55905, United States.
- O'Neal Comprehensive Cancer Center, University of Alabama, Birmingham, AL 35233, United States.
- Division of Hematology and Oncology, University of Alabama at Birmingham, Birmingham, AL 35233, United States.
ORCID-Profile: Anindya Dutta, Wioletta Czaja
Förderung
- NCI NIH HHS
- NIDDK NIH HHS
- NIGMS NIH HHS
- National Institute of Health
- National Scleroderma Foundation
Zitieren
APA
Joseph, J. T., Wright, C. M., Peixoto, E., Shibata, E., Khan, A., Li, Y., Neidigk, J. S. R., Chen, B. R., Tufail, S., Mujawar, A. A., Decker, O., Kadali, K. R., Imtiaz, A., Jones, B. A., Zhang, Y., Gradilone, S. A., Lewis, Z. A., Contreras-Galindo, R., Sen, A., …, & Czaja, W. (2025). The chromatin regulator HELLS mediates SSB repair and responses to DNA alkylation damage. Nucleic Acids Research, 53(22). https://doi.org/10.1093/nar/gkaf1201
Vancouver
Joseph JT, Wright CM, Peixoto E, Shibata E, Khan A, Li Y, et al. The chromatin regulator HELLS mediates SSB repair and responses to DNA alkylation damage. Nucleic Acids Research. 2025;53(22). doi:10.1093/nar/gkaf1201
BibTeX
@article{Joseph2025,
author = {Joseph, Joyous T and Wright, Christine M and Peixoto, Estanislao and Shibata, Etsuko and Khan, Asad and Li, Yong and Neidigk, Jason S Romero and Chen, Bo-Ruei and Tufail, Saba and Mujawar, Aaiyas Abdulhamid and Decker, Olivia and Kadali, Krishna Reethika and Imtiaz, Azait and Jones, Brianna A and Zhang, Yanfeng and Gradilone, Sergio A and Lewis, Zachary A and Contreras-Galindo, Rafael and Sen, Arko and Dutta, Anindya and Czaja, Wioletta},
title = {The chromatin regulator HELLS mediates SSB repair and responses to DNA alkylation damage},
journal = {Nucleic Acids Research},
year = {2025},
volume = {53},
number = {22},
doi = {10.1093/nar/gkaf1201}
}
EUVIMED